In this study, we demonstrated the exploitation of CRISPR/Cas9 as a high precision system for editing the ... whereby modified cells are absent from the final grafting product. Our work illustrates ...

CRISPR Therapeutics recently announced the departure ... Despite some promising product announcements, such as the FDA's RMAT designation for CTX112, these developments have not compensated ...

According to Bloomberg News, the U.S. District Judge Brian Martinotti approved the deal on Tuesday after NVO, among other things, agreed to cap out-of-pocket expenses for its insulin products at $ ...

A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon Athletica founder Chip Wilson — to push a next-generation CRISPR drug ...

aRheumatology Department, Strasbourg University Hospital, Centre de référence pour les maladies auto-immunes systémiques Est – Sud Ouest (RESO), Strasbourg, France bDepartment of Physiology, Muscle ...

EPI-321, the startup’s lead program, uses CRISPR tools to stop errant expression of a gene implicated in the muscle-wasting condition. Epicrispr will start a Phase 1 trial this year in New Zealand, ...

TULSA, OKLA. (KTUL) — A new piece of legislation designed to make insulin products more affordable has successfully passed the Oklahoma House and is now heading to the Senate for further review.

Methods: NEU1 expression in liver cancer was evaluated using public databases and validated in our samples. CRISPR/Cas9, CCK-8 assay, transwell assays, oil red O staining, RNA-sequencing, ...

Just like Taylor Swift during her Eras Tour, it seems like weight loss supplements are everywhere right now—and that includes insulin resistance ... but we only recommend products we back.

Studies have shown that SWELL1 is extensively involved in physiological processes in peripheral metabolic tissues, including adipocyte hypertrophy, skeletal muscle volume regulation, insulin secretion ...